StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) stock

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.56−0.02 (-3.76%)

Close on Nov 19, 2026Market cap $13.12MP/E –Yield –

Genenta Science S.p.A. free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

For fiscal 2025 it was -€6.88M. The highest annual figure on record is -€6.07M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-€6.88M–
FY2024Dec 31, 2024-€6.24M–
FY2023Dec 31, 2023-€11.22M–
FY2022Dec 31, 2022-€7.45M–
FY2021Dec 31, 2021-€6.97M–
FY2020Dec 31, 2020-€6.07M–

More Genenta Science S.p.A. figures

See a number that looks wrong?